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Background
Evaluate the knowledge of physicians who work in
emergency services in the City of São Paulo on terms,
management and conditions related to anaphylaxis.
Methods
Descriptive study. After signing the term of free and
informed consent, physicians who work in emergency
services in the city of São Paulo were asked to answer a
questionnaire.
Results
Out of 177 physicians invited to take part of the survey,
only 77 accepted. Out of which, 48,1% have already trea-
ted an anaphylactic reaction. Eventhough 49% deny ever
having attended a case, they claim having treated of
alergy set on more than one organic system.
As a non-pharmacologic measure, the most mentioned
was oxygen. As a pharmacologic measure, adrenalin was
the choice of 69% of physicians, also mentioning the
intramuscular pathway only by 51,85%. Corticosteroids
were chosen as a consecution for the initial therapy by
19,6%. Glucagon was elected by four physicians as an
alternative therapy for the management of a refractory
anaphylactic reaction in patients in cronic use of beta
blockers. Out of the 77 doctors, 16 (20,77%) already
heard of biphasic anaphylactic reactions, while 79,23%
had no acknowledgement.
Conclusions
49% of the interviewee proved not knowing the actual
criteria for diagnosing anaphylaxis. As the late diagnosis
diminishes the survival rate of these patients, it is
important to elevate the knowledge on this subject for
doctors working on emergency services.
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